Reidy Christopher R 4
4 · Encompass Health Corp · Filed Jul 16, 2026
Research Summary
AI-generated summary of this filing
Encompass Health (EHC) Director Christopher Reidy Receives RSUs
What Happened Christopher R. Reidy, a non-employee director of Encompass Health Corp (EHC), recorded two acquisitions. On 2026-07-15 he was credited 21 restricted stock units (RSUs) tied to the company dividend (reported at $0.00 per share). On 2026-07-16 he acquired 319 shares at $112.40 each, a purchase totaling $35,856 under the company’s directors’ deferred stock plan. Both transactions are reported as acquisitions/awards (code A).
Key Details
- Transaction dates and amounts:
- 2026-07-15: 21 RSUs credited @ $0.00 (dividend-related award).
- 2026-07-16: 319 shares acquired @ $112.40 each = $35,856.
- Dividend and price used for RSU crediting: dividend $0.19 per share (paid 7/15/2026); closing price used for the RSU calculation was $109.88 (per filing footnote).
- Shares owned after the transactions: Not specified in this Form 4.
- Footnotes:
- F1: The 21 RSUs were credited under outstanding RSU award agreements as a dividend-equivalent—number of RSUs equals dividend amount divided by closing price on the dividend payment date.
- F2: The 319 shares were purchased by the Directors Deferred Stock Investment Plan using director fee deferrals and the reinvested dividend; purchases were made in the market by the plan administrator.
- Filing timeliness: Report filed 2026-07-16 for transactions on 2026-07-15 and 07-16 — appears timely (no late filing indicated).
Context These are director compensation/deferral-related acquisitions rather than open-market purchases initiated directly by the director. RSU credits tied to dividends and purchases via a directors’ deferral plan are common and reflect routine compensation deferral and dividend reinvestment, not necessarily a separate personal investment decision.
Insider Transaction Report
- Award
Encompass Health Common Stock
[F1]2026-07-15+21→ 17,458 total - Award
Encompass Health Common Stock
[F2]2026-07-16$112.40/sh+319$35,856→ 17,777 total
Footnotes (2)
- [F1]Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.
- [F2]The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2025 to defer fixed percentages of their director fees for 2026. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the director's fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly fee deferral and the dividend of $0.19 per share paid on July 15, 2026.